Court Denies Seroquel Plaintiffs' Motion for De-Designation of Documents

ORLANDO, Fla. - A federal magistrate judge has denied as untimely Seroquel plaintiffs' motion to compel AstraZeneca to de-designate documents withheld from production based on privileged assertions. In re Seroquel Products Liability Litigation, No. 06-1769 (M.D. Fla.).

On Nov. 6, Magistrate Judge David A. Baker of the U.S. District Court for the Middle District of Florida ruled that the plaintiffs filed their motion"nearly a year late" without any explanation for the delay.

Plaintiffs allege that AstraZeneca failed to properly warn consumers that Seroquel, an atypical antipsychotic medication, may cause diabetes and related disorders.

In January 2008, plaintiffs moved to …